The 2021 Crohn’s & Colitis Congress® Goes Virtual

We are thrilled to announce that the Crohn’s & Colitis Congress®, a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association, will be a virtual experience taking place  January 21-24, 2021.

As always, we will bring together our community of health care practitioners and researchers to continue our mission of transforming inflammatory bowel disease (IBD) care — in a new and exciting forum.  Please continue to check back for updates. We look forward to seeing you virtually.

Dates to Remember

Early Bird Registration Deadline: Wednesday, September 23

Discounted Registration Deadline: Wednesday, December 11

Abstract Submission Opens: Wednesday, September 9

Abstract Submission Closes: Wednesday, October 21

Abstract Notifications: Friday, December 4

Play Video

Dates to Remember

Abstract Submission

Abstract Submission Opens: Monday, September 14
Abstract Submission Closes: Wednesday, October 21
Abstract Notifications: Monday, December 7

Registration

Registration Opens: Friday, August 6
Early Bird Registration Deadline: Wednesday, November 3

Crohn's & Colitis Congress Chairs

David T. Rubin, MD, AGAF

Chair, Organizing Committee
University of Chicago
Bruce-Sands-Edit@2x

Bruce E. Sands, MD, MS, AGAF

Co-Chair, Organizing Committee
Icahn School of Medicine at Mount Sinai

Supporting Organizations

The 2021 Crohn’s & Colitis Congress is supported by educational grants from:

AbbVie Inc.

Amgen Inc.

Bristol Myers Squibb

Ferring Pharmaeuticals Inc.

Gilead Sciences, Inc.

Janssen Biotech, Inc.

Pfizer, Inc.

Salix, a division of Bausch Health US, LLC.

Takeda Pharmaceuticals U.S.A., Inc.

Media Partners

The 2021 Crohn’s & Colitis Congress is partnered with: